Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Financial Flexibility Index
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥131.84 Million (operating CF CN¥110.78 Million minus capex CN¥21.06 Million) represents 0% of total liabilities (CN¥2.56 Billion). Check 600329 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Financial Flexibility Index (2001–2024)
Historical Financial Flexibility Index trend for Tianjin Zhongxin Pharmaceutical Group Corp Ltd across 24 annual periods. For the full cash flow conversion analysis, see Tianjin Zhongxin Pharmaceutical Group Co (600329) cash flow conversion.
Annual Financial Flexibility Index for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Year-by-year free cash flow to debt coverage for Tianjin Zhongxin Pharmaceutical Group Corp Ltd. Explore Tianjin Zhongxin Pharmaceutical Group Co cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.36x | CN¥1.04 Billion | CN¥924.67 Million | CN¥2.92 Billion | ▲ +54.4% |
| 2023 | 0.23x | CN¥829.42 Million | CN¥688.49 Million | CN¥3.58 Billion | ▲ +6.2% |
| 2022 | 0.22x | CN¥785.15 Million | CN¥677.25 Million | CN¥3.61 Billion | ▼ -44.9% |
| 2021 | 0.40x | CN¥1.01 Billion | CN¥852.40 Million | CN¥2.55 Billion | ▲ +7.2% |
| 2020 | 0.37x | CN¥860.58 Million | CN¥671.42 Million | CN¥2.33 Billion | ▲ +22.0% |
| 2019 | 0.30x | CN¥701.10 Million | CN¥495.49 Million | CN¥2.32 Billion | ▲ +17.8% |
| 2018 | 0.26x | CN¥525.95 Million | CN¥350.14 Million | CN¥2.05 Billion | ▲ +363.5% |
| 2017 | 0.06x | CN¥110.45 Million | CN¥-3.97 Million | CN¥2.00 Billion | ▼ -78.8% |
| 2016 | 0.26x | CN¥536.10 Million | CN¥419.90 Million | CN¥2.06 Billion | ▲ +12.8% |
| 2015 | 0.23x | CN¥453.22 Million | CN¥360.58 Million | CN¥1.96 Billion | ▲ +61.0% |
| 2014 | 0.14x | CN¥357.01 Million | CN¥286.85 Million | CN¥2.49 Billion | ▲ +34.8% |
| 2013 | 0.11x | CN¥285.86 Million | CN¥213.44 Million | CN¥2.69 Billion | ▲ +267.5% |
| 2012 | 0.03x | CN¥61.98 Million | CN¥20.81 Million | CN¥2.14 Billion | ▼ -74.1% |
| 2011 | 0.11x | CN¥216.90 Million | CN¥173.88 Million | CN¥1.94 Billion | ▼ -5.8% |
| 2010 | 0.12x | CN¥207.82 Million | CN¥139.04 Million | CN¥1.75 Billion | ▲ +31.2% |
| 2009 | 0.09x | CN¥170.15 Million | CN¥83.41 Million | CN¥1.88 Billion | ▼ -8.0% |
| 2008 | 0.10x | CN¥194.13 Million | CN¥155.77 Million | CN¥1.97 Billion | ▲ +183.4% |
| 2007 | 0.03x | CN¥73.87 Million | CN¥20.13 Million | CN¥2.13 Billion | ▲ +104.4% |
| 2006 | 0.02x | CN¥35.66 Million | CN¥-28.08 Million | CN¥2.10 Billion | ▼ -91.3% |
| 2005 | 0.20x | CN¥411.70 Million | CN¥261.91 Million | CN¥2.11 Billion | ▲ +51.4% |
| 2004 | 0.13x | CN¥262.80 Million | CN¥10.50 Million | CN¥2.04 Billion | ▼ -62.0% |
| 2003 | 0.34x | CN¥665.77 Million | CN¥76.57 Million | CN¥1.96 Billion | ▲ +21.8% |
| 2002 | 0.28x | CN¥368.00 Million | CN¥187.60 Million | CN¥1.32 Billion | ▲ +12.7% |
| 2001 | 0.25x | CN¥291.68 Million | CN¥157.73 Million | CN¥1.18 Billion | — |